Equity research of novo Nordisk - a shift in focus: from insulin to GLP-1

This equity research has the purpose of projecting Novo Nordisk’s operations within the next5 years. There is a growing trend in the company’s focus towards the GLP-1 segment, shifting away from the traditional focus on in sulinglargine. In addition, there is a perception that insulin industry compe...

Full description

Bibliographic Details
Main Author: Cavalcanti, Eduardo Burguet (author)
Format: masterThesis
Language:eng
Published: 2022
Subjects:
Valuation
Forecasting
Health
Finance
Equity research
Health care
Insulin
Pharmaceutical industry
Patents
Glp-1
Obesity
Pipeline
Pharmaceuticals
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
Online Access:http://hdl.handle.net/10362/144714
Country:Portugal
Oai:oai:run.unl.pt:10362/144714

Internet

http://hdl.handle.net/10362/144714

Similar Items